To promote skin cancer awareness during Melanoma Awareness Month, La Roche-Posay is hosting its second annual Become a Skin Checker event.

Part of this year’s event will be providing a solution to acelerate patient access to care and treatment for a suspicious mole or lesion by offering examinations via teledermatology, the latest technological innovation in the dermatology field and the future of skin cancer detection.

With the use of a medical device with a smart phone, teledermatology gives general practitioners the ability to quickly and effectively share high-resolution images with a dermatologist, regardless the distance of their practice, for evaluation via a secured platform.

Having suspicious moles evaluated with teledermatology reduces the wait-time and increases accessibility so dermatologists can focus on critical cases and seeing the right patient, at the right time.

“Skin cancer prevention is at the heart of La Roche-Posay’s DNA, and we are committed to supporting the dermatologist community and finding solutions for earlier skin cancer detection”, said Josée Bordeleau, Medical Relations Manager, La Roche-Posay.

Bordeleau continues, “Teledermatology is the future for detecting and treating skin cancer early. We’re proud to be part of this initiative and bringing the technology to the forefront of the conversation in how we can reduce skin cancer in Canada.”